PubRank

Adi Gazdar

Author PubWeight™ 160.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High frequency of mutations of the PIK3CA gene in human cancers. Science 2004 27.94
2 A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006 27.36
3 International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011 21.49
4 A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2009 18.39
5 High-throughput oncogene mutation profiling in human cancer. Nat Genet 2007 12.68
6 MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci U S A 2007 11.85
7 Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res 2005 3.98
8 Genetic predictors of MEK dependence in non-small cell lung cancer. Cancer Res 2008 2.71
9 Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst 2008 2.15
10 Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 2012 1.98
11 High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol 2015 1.93
12 EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res 2007 1.91
13 Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin Cancer Res 2009 1.83
14 Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels. Clin Cancer Res 2006 1.82
15 A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Clin Cancer Res 2004 1.73
16 Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer. J Thorac Oncol 2006 1.72
17 In vivo optical coherence tomography imaging of preinvasive bronchial lesions. Clin Cancer Res 2008 1.50
18 Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 2012 1.45
19 Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2008 1.38
20 Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod Pathol 2012 1.33
21 Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007 1.22
22 Natural history of bronchial preinvasive lesions. Cancer Metastasis Rev 2010 1.21
23 Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: an international, multicenter clinical trial. J Thorac Oncol 2009 1.20
24 Retracted Aberrant methylation of heparan sulfate glucosamine 3-O-sulfotransferase 2 genes as a biomarker in colorectal cancer. Anticancer Res 2010 1.18
25 Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Hum Mutat 2006 1.12
26 Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1. Cancer Res 2009 1.08
27 Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer 2007 1.06
28 Pathologic findings of lung tumors diagnosed on baseline CT screening. Am J Surg Pathol 2006 1.03
29 Cumulative effect of multiple loci on genetic susceptibility to familial lung cancer. Cancer Epidemiol Biomarkers Prev 2010 1.01
30 Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. Cancer Res 2007 0.98
31 A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers. Cancer Res 2010 0.98
32 Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Lab Invest 2008 0.96
33 Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia. Int J Oncol 2003 0.92
34 Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines. Cancer Res 2002 0.90
35 Nuclear morphometry as a biomarker for bronchial intraepithelial neoplasia: correlation with genetic damage and cancer development. Cytometry A 2005 0.88
36 CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer. J Thorac Oncol 2013 0.86
37 Two somatic biallelic lesions within and near SMAD4 in a human breast cancer cell line. Genes Chromosomes Cancer 2005 0.85
38 Automated sputum cytometry for detection of intraepithelial neoplasias in the lung. Anal Cell Pathol (Amst) 2012 0.81
39 A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. Cancer Res 2010 0.81
40 SV40 and human brain tumors. Int J Cancer 2003 0.78
41 Identification of breast cancer DNA methylation markers optimized for fine-needle aspiration samples. Cancer Epidemiol Biomarkers Prev 2013 0.77